Cite

HARVARD Citation

    Unknown (2020). Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. QRB discovery. p. . [Online]. 
  
Back to record